This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).
ORIGINAL RESEARCH
Additional education in the field of biomedicine (Cellular and genetic therapy)
1 Federal State Autonomous Educational Institution of Higher Education «Russian National Research Medical University named after N.I. Pirogov» Ministry of Health of the Russian Federation
2 Federal State Budgetary Institution of Science “Institute of Developmental Biology named after N.K. Koltsov RAS”
3 Company «AkRusBiomed»
The work was financially supported by the Ministry of Science and Higher Education of the Russian Federation under Agreement No. 075-15-2021-1075 dated September 28, 2021 (Research program "The use of genetic technologies for the search for biomarkers, modeling and therapy of human diseases").
- Sukhanov YU.V., Vorotelyak Ye.A., Lyadova I.V., Vasil'yev A.V.. Terapiya mezenkhimal’nymi stvolovymi kletkami – sosud napolovinu polon ili napolovinu pust? / Yu.V. Sukhanov, Ye.A. Vorotelyak, I.V. Lyadova, A.V. Vasil’yev. // Ontogenez. — 2020, — tom 51, № 4, — S. 316–320.
- Golchin A. Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility / A. Golchin // Stem Cell Reviews and Reports (2021) — 17:56–62.
- Chu G. at all. Stem cell therapy on skin: Mechanisms, recent advances and drug reviewing issues. / Gong-Yau Chu, Yu-Fu Chen, Hsiao-Yun Chen, Ming-Hsiao Chan, Churn-Shiouh Gau, Shih-Ming Weng // Journal of food and drug analysis — 26 (2018) — p. 14-20.
- Shukla V. at all. The Landscape of Cellular and Gene Therapy Products: Authorization, Discontinuations, and Cost. / Vaishali Shukla, Enrique Seoane-Vazquez, Souhiela Fawaz, Lawrence Brown, and Rosa Rodriguez-Monguio // Human gene therapy clinical development, — 2019, — volume 30 number 3, — p. 102-113.